The Union government has made an interim allocation of tocilizumab among the states, as a fresh limited stock of the drug used for the treatment of COVID-19 patients has arrived in the country. In a letter, Pharma Joint Secretary Navdeep Rinwa and Health and Family Welfare Ministry Director Rajiv Wadhawan said the drug went out of stock in the country a few weeks ago due to a sudden surge in its demand because of a sharp rise in COVID-19 cases in the country. Fresh limited stock of this drug has now been imported and is available with lone marketer company Cipla Ltd formarketing and distribution in the country, the letter said.
Govt makes interim allocation of COVID-19 treatment drug Tocilizumab to states
Fresh limited stock of this drug has now been imported and is available with lone marketer company Cipla Ltd for marketing and distribution in the country, the letter said.
Share Via Email
| A+A A- By PTI
NEW DELHI: The Union government has made an interim allocation of Tocilizumab among the states, as a fresh limited stock of the drug used for the treatment of COVID-19 patients has arrived in the country.
In a letter, Pharma Joint Secretary Navdeep Rinwa and Health and Family Welfare Ministry Director Rajiv Wadhawan said the drug went out of stock in the country a few weeks ago due to a sudden surge in its demand because of a sharp rise in COVID-19 cases in the country.